CarTCell® is a cartilage liquid extract with scientifically proven, oral bioavailability.
In 1999, a clinical human study of CarTCell® was published in the peer reviewed Journal of Surgical Research (volume 87, pp. 108–113). The double-blind study (which included a placebo) showed that CarTCell® could be assimilated via the oral route. It is the first time that such bioavailability has been demonstrated for a cartilage extract in a rigorous scientific study.
Atrium uses the most advanced cellular and molecular biology technologies to manufacture CarTCell®. We use an exclusive and patented hypotonic shock cell extraction process to break the cell membrane and extract molecules at low temperatures to preserve the integrity of the molecules and to obtain maximum activity in each bottle. The molecules are separated based on their molecular weights, concentrated, and marketed in a liquid form that can be taken orally.
Unlike other manufacturers, Atrium uses only those molecules that produce the desired effect. That explains why a large number of health professionals around the world now prefer offering their patients CarTCell®.
Liquid CarTCell® compared to Powdered CarTCell®
Our liquid cartilage extract comes from the same biological material as the majority of powders-shark cartilage. In fact, the manufacturing process is what makes all the difference.
Cartilage is a highly hydrated material containing 50% to 80% water, depending on the source. With the CarTCell® manufacturing process, the biologically active substances are kept in their natural aqueous environment.
In addition, our extraction process removes the surrounding matrix, and concentrates bioactive molecules, making the product more potent. This highly bioactive extract is maintained at a low temperature during the entire manufacturing process. The last step uses ultra filtration techniques to concentrate the active fractions. |